These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8171561)

  • 21. Early experience with a long-distance collaborative human islet transplant programme.
    Tibell A; Brendel M; Wadström J; Brandhorst D; Brandhorst H; Eckhard M; Bolinder J; Bretzel RG; Groth CG
    Transplant Proc; 1997 Nov; 29(7):3124-5. PubMed ID: 9365693
    [No Abstract]   [Full Text] [Related]  

  • 22. Deoxyspergualin--a different and intriguing immunosuppressant.
    Tufveson G; Gannedahl G
    Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954
    [No Abstract]   [Full Text] [Related]  

  • 23. Defects in quantitative and qualitative beta-cell function following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation (DSSGMEPT).
    Christiansen E; Tibell A; Rasmussen K; Tydén G; Madsbad S
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1186-9. PubMed ID: 8442082
    [No Abstract]   [Full Text] [Related]  

  • 24. Mode of action of 15-deoxyspergualin in xenografting islets of Langerhans.
    Nakajima Y; Yoshimura A; Kanehiro H; Aomatsu Y; Nakano H
    Transplant Proc; 1994 Jun; 26(3):1093-4. PubMed ID: 8029842
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of the factors influencing successful clinical islet transplantation.
    Farkas G; Karácsonyi S; Herczegh J; Szabó M
    Transplant Proc; 1990 Aug; 22(4):2054. PubMed ID: 2117824
    [No Abstract]   [Full Text] [Related]  

  • 26. Xenotransplantation of pig pancreatic islets to rat using 15-deoxyspergualin monotherapy.
    Jindal RM; Soltys K; Yost F; Beer E; Tepper MA; Cho SI
    Transplant Proc; 1994 Jun; 26(3):1108-9. PubMed ID: 8029848
    [No Abstract]   [Full Text] [Related]  

  • 27. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.
    Keymeulen B; Ling Z; Gorus FK; Delvaux G; Bouwens L; Grupping A; Hendrieckx C; Pipeleers-Marichal M; Van Schravendijk C; Salmela K; Pipeleers DG
    Diabetologia; 1998 Apr; 41(4):452-9. PubMed ID: 9562350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
    Henretta J; Pittman K; McFadden T; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
    [No Abstract]   [Full Text] [Related]  

  • 29. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases.
    Calafiore R; Basta G; Luca G; Lemmi A; Montanucci MP; Calabrese G; Racanicchi L; Mancuso F; Brunetti P
    Diabetes Care; 2006 Jan; 29(1):137-8. PubMed ID: 16373911
    [No Abstract]   [Full Text] [Related]  

  • 30. Allotransplantation of fresh islets in four type I diabetic patients.
    Socci C; Falqui L; Davalli AM; Ricordi C; Bertuzzi F; Braghi S; Maffi P; Secchi A; Gavazzi F; Freschi M
    Transplant Proc; 1992 Jun; 24(3):965-6. PubMed ID: 1604688
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases.
    Basta G; Montanucci P; Luca G; Boselli C; Noya G; Barbaro B; Qi M; Kinzer KP; Oberholzer J; Calafiore R
    Diabetes Care; 2011 Nov; 34(11):2406-9. PubMed ID: 21926290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolongation of islet xenograft survival with combined treatment of 15-deoxyspergualin or cyclosporine and anti-CD4 monoclonal antibody.
    Lu X; Borel JF
    Transplant Proc; 1995 Feb; 27(1):298-9. PubMed ID: 7879010
    [No Abstract]   [Full Text] [Related]  

  • 33. Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases.
    Socci C; Falqui L; Davalli AM; Ricordi C; Braghi S; Bertuzzi F; Maffi P; Secchi A; Gavazzi F; Freschi M
    Acta Diabetol; 1991; 28(2):151-7. PubMed ID: 1777651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human fetal islet transplantation in IDDM patients: an 8-year experience.
    Dordević PB; Lalić NM; Brkić S; Jotić A; Paunović I; Lalić K; Dimitrijević V; Dragasević M; Zamaklar M; Popović S
    Transplant Proc; 1995 Dec; 27(6):3146-7. PubMed ID: 8539884
    [No Abstract]   [Full Text] [Related]  

  • 35. Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases.
    Carroll PB; Ricordi C; Rilo HR; Fontes P; Khan R; Tzakis AG; Shapiro R; Fung JJ; Starzl TE
    Transplant Proc; 1992 Dec; 24(6):3038-9. PubMed ID: 1466046
    [No Abstract]   [Full Text] [Related]  

  • 36. Sustained Islet Allograft Function After Peritransplant Treatment Using Exenatide With and Without Everolimus.
    Bertuzzi F; Marazzi M; De Carlis LG; Rampoldi AG; Bonomo M; Antonioli B; Tosca MC; Galuzzi M; De Gasperi A; Colussi G
    Transplantation; 2016 Nov; 100(11):e117-e118. PubMed ID: 27517727
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term glucose homeostasis and insulin secretion following segmental heterotopic pancreas transplantation.
    Cantarovich D; Murat A; Paineau J; Hourmant M; Baatard R; Dantal J; Soulillou JP
    Transplant Proc; 1992 Jun; 24(3):883. PubMed ID: 1604654
    [No Abstract]   [Full Text] [Related]  

  • 38. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.
    Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH
    Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 15-deoxyspergualin in islet xenograft rejection.
    Yoshimura A; Nakajima Y; Kanehiro H; Nakano H
    Transplant Proc; 1996 Jun; 28(3):1426-7. PubMed ID: 8658724
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative study of the effect of clinical fetal islet transplantation vs insulin therapy.
    Farkas G; Szabó M; Vörös P
    Transplant Proc; 1994 Apr; 26(2):701. PubMed ID: 8171614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.